ARS Pharmaceuticals, Inc. — Director's Dealing 2024

Jun 8, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARS Pharmaceuticals, Inc. (SPRY)
CIK: 0001671858
Period of Report: 2024-06-07

Reporting Person: Shah Pratik (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-07	Common Stock	G	1332950	—	Disposed	4824554	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1332900	Indirect

Footnotes

F1: This transaction involved the gift by The Pratik Shah Living Trust dated June 15, 2011 to The Pratik Shah Trust (the "Shah Trust") of which the Reporting Person's spouse is sole beneficiary. The Reporting Person is grantor of the Shah Trust.

F2: Pratik Shah, Ph.D. is the trustee of The Pratik Shah Living Trust dated June 15, 2011.